Clinical Study
A Pilot Study on Bioactive Constituents and Analgesic Effects of MyrLiq®, a Commiphora myrrha Extract with a High Furanodiene Content
Table 2
Content of furanodienes in the two types of tablets containing either 200 mg or 400 mg of MyrLiq.
| Compound | Furanodiene content in tablets containing 200 mg of MyrLiq (mg) | Furanodiene content in tablets containing 400 mg of MyrLiq (mg) |
| Curzerene | 2.46 | 4.92 | Furanoeudesma-1,3-diene | 3.77 | 7.54 | Lindestrene | 1.25 | 2.50 | Unknown furanodiene (MW = 216) | 0.06 | 0.12 | Dihydrolinderalactone | 0.26 | 0.52 | Acetoxy-furanodiene (MW = 274) | 0.12 | 0.24 | Acetoxy-furanodiene (MW = 232) | 0.25 | 0.50 | Total | 8.17 | 16.34 |
|
|